Drug Information

Drug General Information
Drug ID
D0DR7W
Former ID
DNC011157
Drug Name
Seco-exiguamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529627]
Structure
Download
2D MOL

3D MOL
Formula
C25H29N5O6
Canonical SMILES
CN1C(C(=O)N(C1=O)C)C2=C(C3=C(C(=C2C4=C(C=CC(=O)C4=O)CCN<br />(C)C)O)NC=C3CCN)O
InChI
1S/C25H29N5O6/c1-28(2)10-8-12-5-6-14(31)21(32)15(12)17-18(20-24(35)30(4)25(36)29(20)3)22(33)16-13(7-9-26)11-27-19(16)23(17)34/h5-6,11,20,27,33-34H,7-10,26H2,1-4H3
InChIKey
DKHMMLOHGSGPQL-UHFFFAOYSA-N
PubChem Compound ID
24856336
Target and Pathway
Target(s) Indoleamine 2,3-dioxygenase Target Info Inhibitor [529627]
BioCyc Pathway Superpathway of tryptophan utilization
Tryptophan degradation
L-kynurenine degradation
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
NAD de novo biosynthesis
KEGG Pathway Tryptophan metabolism
Metabolic pathways
African trypanosomiasis
NetPath Pathway TSLP Signaling Pathway
IL5 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Tryptophan Metabolism
Reactome Tryptophan catabolism
WikiPathways Tryptophan metabolism
Metabolism of amino acids and derivatives
References
Ref 529627Nat Chem Biol. 2008 Sep;4(9):535-7.Biomimetic synthesis of the IDO inhibitors exiguamine A and B.
Ref 529627Nat Chem Biol. 2008 Sep;4(9):535-7.Biomimetic synthesis of the IDO inhibitors exiguamine A and B.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.